These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33796141)

  • 1. Paraneoplastic neurological syndromes: clinical presentations and management.
    Devine MF; Kothapalli N; Elkhooly M; Dubey D
    Ther Adv Neurol Disord; 2021; 14():1756286420985323. PubMed ID: 33796141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes.
    Farina A; Villagrán-García M; Vogrig A; Zekeridou A; Muñiz-Castrillo S; Velasco R; Guidon AC; Joubert B; Honnorat J
    Lancet Neurol; 2024 Jan; 23(1):81-94. PubMed ID: 38101905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic neurological syndromes and onconeural antibodies: clinical and immunological aspects.
    Storstein A; Vedeler CA
    Adv Clin Chem; 2007; 44():143-85. PubMed ID: 17682342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series.
    Giammello F; Galletta K; Grillo F; Brizzi T; Cavallaro M; Mormina E; Scelzo E; Allegra C; Stancanelli C; Rodolico C; Musumeci O; Toscano A; Granata F
    Acta Neurol Belg; 2023 Aug; 123(4):1355-1369. PubMed ID: 36884202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraneoplastic neurologic syndromes in children: a review article.
    Alavi S
    Iran J Child Neurol; 2013; 7(3):6-14. PubMed ID: 24665300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic neurological syndrome: an evolving story.
    Jitprapaikulsan J; Paul P; Thakolwiboon S; Mittal SO; Pittock SJ; Dubey D
    Neurooncol Pract; 2021 Aug; 8(4):362-374. PubMed ID: 34277016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic neurological syndrome: growing spectrum and relevance.
    Ganaraja VH; Rezk M; Dubey D
    Neurol Sci; 2022 Jun; 43(6):3583-3594. PubMed ID: 35460452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
    Braik T; Evans AT; Telfer M; McDunn S
    Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Non-classical" paraneoplastic neurological syndromes associated with well-characterized antineuronal antibodies as compared to "classical" syndromes - More frequent than expected.
    Berger B; Bischler P; Dersch R; Hottenrott T; Rauer S; Stich O
    J Neurol Sci; 2015 May; 352(1-2):58-61. PubMed ID: 25824848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on paraneoplastic syndromes.
    Dropcho EJ
    Curr Opin Neurol; 2005 Jun; 18(3):331-6. PubMed ID: 15891421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective study of paraneoplastic neurological syndromes in a Chinese Han population from Shandong, East China.
    Miao S; Liao S; Li H; Niu B; Hu H; Qian Y; Guo H; Cao B
    Int J Neurosci; 2018 Sep; 128(9):821-827. PubMed ID: 29355452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic Neurologic Disorders.
    Gilligan M; McGuigan C; McKeon A
    Curr Neurol Neurosci Rep; 2023 Mar; 23(3):67-82. PubMed ID: 36781586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Onconeural antibodies as a tool for diagnosis of malignant tumors and paraneoplastic neurological disorders].
    Belousov PV; Shebzukhov IuV; Nedospasov SA; Kuprash DV
    Mol Gen Mikrobiol Virusol; 2007; (2):6-13. PubMed ID: 17598451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraneoplastic antigens as biomarkers for early diagnosis of ovarian cancer.
    Chatterjee M; Hurley LC; Tainsky MA
    Gynecol Oncol Rep; 2017 Aug; 21():37-44. PubMed ID: 28653032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraneoplastic Neurological Syndromes and Beyond Emerging With the Introduction of Immune Checkpoint Inhibitor Cancer Immunotherapy.
    Valencia-Sanchez C; Zekeridou A
    Front Neurol; 2021; 12():642800. PubMed ID: 33897597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal synthesis of onconeural antibodies in patients with paraneoplastic syndromes.
    Corsini E; Gaviani P; Chiapparini L; Lazzaroni M; Ciusani E; Bisogno R; Silvani A; Salmaggi A; Bernardi G
    J Neuroimmunol; 2016 Jan; 290():119-22. PubMed ID: 26711581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Ri-associated paraneoplastic ophthalmoplegia-ataxia syndrome in a woman with breast cancer: a case report and review of the literature.
    Sena G; Gallo G; Vescio G; Gambardella D; de Franciscis S; Renne M
    J Med Case Rep; 2020 Jun; 14(1):67. PubMed ID: 32527295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies.
    Raspotnig M; Vedeler C; Storstein A
    J Neurol Sci; 2015 Jan; 348(1-2):41-5. PubMed ID: 25467140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraneoplastic syndromes affecting the nervous system.
    Dalmau JO; Posner JB
    Semin Oncol; 1997 Jun; 24(3):318-28. PubMed ID: 9208887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paraneoplastic neurological syndromes in 2008].
    Honnorat J
    Rev Neurol (Paris); 2009 May; 165 Suppl 3():S59-65. PubMed ID: 19524096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.